checkAd

     125  0 Kommentare Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19 - Seite 2

    Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group. May 2020 Ascendis Pharma A/S.

    Investor contact:                                                                               
    Patti Bank                                                                                           
    Westwicke Partners                                                                            
    (415) 513-1284                                                                                             
    patti.bank@westwicke.com                                                               
    ir@ascendispharma.com             

    Lesen Sie auch

    Media contact:
    Ami Knoefler
    Ascendis Pharma
    (650) 739-9952 
    ack@ascendispharma.com

    Seite 2 von 2




    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19 - Seite 2 COPENHAGEN, Denmark, May 07, 2020 (GLOBE NEWSWIRE) - Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that the company will hold a …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer